Andrzej
Analyst
Guggenheim Securities
Equibles does not estimate personal net worth.
About Andrzej
Andrzej is recorded as Analyst at Guggenheim Securities. Andrzej has spoken on 1 investor event across 1 company, most recently for Opus Genetics, Inc. on November 10, 2026. The companies whose calls Andrzej spoke on are classified in the Healthcare sector.
Andrzej on recent calls
“Maybe, you know, going to pivotal trial and the alignment with the FDA about the endpoint, I think you have seven pre-specified endpoints that should show statistical significance in improvement.”
Affiliation history
-
Guggenheim Securities
Analyst
Transcript header (unverified)
Current